EMEA (European Medicines Evaluation Agency) and the new pharmaceutical procedures for Europe.

Abstract

Regulation of medicines in the United Kingdom has changed considerably since the establishment of the Medicines Control Agency in 1989, and other changes will take place throughout the European Community (EC) over the next few years. 1995 will see the introduction of a centralised procedure, applicable to a small number of innovative drugs, and a decentralised procedure, based on mutual recognition of licences granted by existing control authorities in other EC countries.